These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 27014752)
1. Altered Expression of Angiotensinogen and Mediators of Angiogenesis in Ileal Crohn's Disease. Hume GE; Doecke JD; Huang N; Fowler EV; Brown IS; Simms LA; Radford-Smith GL J Gastrointestin Liver Dis; 2016 Mar; 25(1):39-48. PubMed ID: 27014752 [TBL] [Abstract][Full Text] [Related]
2. Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease. Simms LA; Doecke JD; Walsh MD; Huang N; Fowler EV; Radford-Smith GL Gut; 2008 Jul; 57(7):903-10. PubMed ID: 18305068 [TBL] [Abstract][Full Text] [Related]
3. NOD2 status and human ileal gene expression. Hamm CM; Reimers MA; McCullough CK; Gorbe EB; Lu J; Gu CC; Li E; Dieckgraefe BK; Gong Q; Stappenbeck TS; Stone CD; Dietz DW; Hunt SR Inflamm Bowel Dis; 2010 Oct; 16(10):1649-57. PubMed ID: 20155851 [TBL] [Abstract][Full Text] [Related]
4. NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression. Wehkamp J; Harder J; Weichenthal M; Schwab M; Schäffeler E; Schlee M; Herrlinger KR; Stallmach A; Noack F; Fritz P; Schröder JM; Bevins CL; Fellermann K; Stange EF Gut; 2004 Nov; 53(11):1658-64. PubMed ID: 15479689 [TBL] [Abstract][Full Text] [Related]
5. KCNN4 gene variant is associated with ileal Crohn's Disease in the Australian and New Zealand population. Simms LA; Doecke JD; Roberts RL; Fowler EV; Zhao ZZ; McGuckin MA; Huang N; Hayward NK; Webb PM; Whiteman DC; Cavanaugh JA; McCallum R; Florin TH; Barclay ML; Gearry RB; Merriman TR; Montgomery GW; Radford-Smith GL Am J Gastroenterol; 2010 Oct; 105(10):2209-17. PubMed ID: 20407432 [TBL] [Abstract][Full Text] [Related]
6. IL23R-Protective Coding Variant Promotes Beneficial Bacteria and Diversity in the Ileal Microbiome in Healthy Individuals Without Inflammatory Bowel Disease. Zakrzewski M; Simms LA; Brown A; Appleyard M; Irwin J; Waddell N; Radford-Smith GL J Crohns Colitis; 2019 Mar; 13(4):451-461. PubMed ID: 30445599 [TBL] [Abstract][Full Text] [Related]
7. Altered microRNA expression in inflamed and non-inflamed terminal ileal mucosa of adult patients with active Crohn's disease. Guo Z; Wu R; Gong J; Zhu W; Li Y; Wang Z; Li N; Li J J Gastroenterol Hepatol; 2015 Jan; 30(1):109-16. PubMed ID: 24910152 [TBL] [Abstract][Full Text] [Related]
8. Crohn disease-associated Escherichia coli promote gastrointestinal inflammatory disorders by activation of HIF-dependent responses. Mimouna S; Gonçalvès D; Barnich N; Darfeuille-Michaud A; Hofman P; Vouret-Craviari V Gut Microbes; 2011; 2(6):335-46. PubMed ID: 22157238 [TBL] [Abstract][Full Text] [Related]
9. Increased lymphatic vessel density and lymphangiogenesis in inflammatory bowel disease. Rahier JF; De Beauce S; Dubuquoy L; Erdual E; Colombel JF; Jouret-Mourin A; Geboes K; Desreumaux P Aliment Pharmacol Ther; 2011 Sep; 34(5):533-43. PubMed ID: 21736598 [TBL] [Abstract][Full Text] [Related]
10. Increased epithelial uptake of protein antigens in the ileum of Crohn's disease mediated by tumour necrosis factor alpha. Söderholm JD; Streutker C; Yang PC; Paterson C; Singh PK; McKay DM; Sherman PM; Croitoru K; Perdue MH Gut; 2004 Dec; 53(12):1817-24. PubMed ID: 15542521 [TBL] [Abstract][Full Text] [Related]
11. Influence of Crohn's disease related polymorphisms in innate immune function on ileal microbiome. Li E; Zhang Y; Tian X; Wang X; Gathungu G; Wolber A; Shiekh SS; Sartor RB; Davidson NO; Ciorba MA; Zhu W; Nelson LM; Robertson CE; Frank DN PLoS One; 2019; 14(2):e0213108. PubMed ID: 30818349 [TBL] [Abstract][Full Text] [Related]
12. Expression of NOD2 in Paneth cells: a possible link to Crohn's ileitis. Ogura Y; Lala S; Xin W; Smith E; Dowds TA; Chen FF; Zimmermann E; Tretiakova M; Cho JH; Hart J; Greenson JK; Keshav S; Nuñez G Gut; 2003 Nov; 52(11):1591-7. PubMed ID: 14570728 [TBL] [Abstract][Full Text] [Related]
13. Increased production of retinoic acid by intestinal macrophages contributes to their inflammatory phenotype in patients with Crohn's disease. Sanders TJ; McCarthy NE; Giles EM; Davidson KL; Haltalli ML; Hazell S; Lindsay JO; Stagg AJ Gastroenterology; 2014 May; 146(5):1278-88.e1-2. PubMed ID: 24503130 [TBL] [Abstract][Full Text] [Related]
14. The ATG16L1-T300A allele impairs clearance of pathosymbionts in the inflamed ileal mucosa of Crohn's disease patients. Sadaghian Sadabad M; Regeling A; de Goffau MC; Blokzijl T; Weersma RK; Penders J; Faber KN; Harmsen HJ; Dijkstra G Gut; 2015 Oct; 64(10):1546-52. PubMed ID: 25253126 [TBL] [Abstract][Full Text] [Related]
15. Inflammatory gene expression profiles in Crohn's disease and ulcerative colitis: a comparative analysis using a reverse transcriptase multiplex ligation-dependent probe amplification protocol. Gologan S; Iacob R; Iancu D; Iacob S; Cotruta B; Vadan R; Catuneanu AM; Constantinescu I; Barbarii L; Gheorghe C; Diculescu M J Crohns Colitis; 2013 Sep; 7(8):622-30. PubMed ID: 23014361 [TBL] [Abstract][Full Text] [Related]
16. Angiotensinogen and transforming growth factor beta1: novel genes in the pathogenesis of Crohn's disease. Hume GE; Fowler EV; Lincoln D; Eri R; Templeton D; Florin TH; Cavanaugh JA; Radford-Smith GL J Med Genet; 2006 Oct; 43(10):e51. PubMed ID: 17047091 [TBL] [Abstract][Full Text] [Related]
17. Interferon Lambda Promotes Paneth Cell Death Via STAT1 Signaling in Mice and Is Increased in Inflamed Ileal Tissues of Patients With Crohn's Disease. Günther C; Ruder B; Stolzer I; Dorner H; He GW; Chiriac MT; Aden K; Strigli A; Bittel M; Zeissig S; Rosenstiel P; Atreya R; Neurath MF; Wirtz S; Becker C Gastroenterology; 2019 Nov; 157(5):1310-1322.e13. PubMed ID: 31352002 [TBL] [Abstract][Full Text] [Related]
18. Identifying the importance of PCK1 in maintaining ileal epithelial barrier integrity in Crohn's disease. Yang D; Li P; Dang Y; Zhu S; Shi H; Wu T; Zhang Z; Chen C; Zong Y Gene; 2024 Dec; 931():148872. PubMed ID: 39159791 [TBL] [Abstract][Full Text] [Related]
20. NOD2 Is Regulated By Mir-320 in Physiological Conditions but this Control Is Altered in Inflamed Tissues of Patients with Inflammatory Bowel Disease. Pierdomenico M; Cesi V; Cucchiara S; Vitali R; Prete E; Costanzo M; Aloi M; Oliva S; Stronati L Inflamm Bowel Dis; 2016 Feb; 22(2):315-26. PubMed ID: 26752466 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]